Last Updated:
Access Report
Name Designation Appointment Date Status
Rupesh Mishra

Appointed as Director since April 2019

 Director 15-Apr-2019 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ayush Prasad

Appointed as Additional Director since January 2025

 Additional Director 06-Jan-2025 Current

People Timeline

Explore the timeline of key personnel in Reivas Pharmaceutical Private Limited's leadership journey.

Contact Details
  • Address C/O Arun Kumar Mehta, Ward No-33, Khata No. 17,Plot No. 135, Thana No. 202,, Hehal, Devi Mandap Road, Jharkhand, 834005, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 834005
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Reivas Pharmaceutical Private Limited?
You can contact Reivas Pharmaceutical Private Limited through their registered address at C/O Arun Kumar Mehta, Ward No-33, Khata No. 17,Plot No. 135, Thana No. 202,, Hehal, Devi Mandap Road, Jharkhand, 834005, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Reivas Pharmaceutical Private Limited?
The current directors of Reivas Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RUPESH MISHRA
  • Ayush Prasad
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available